Likewise, Drachenberg et al (1999) reported high concentrations of IL-6 in men with hormone refractory prostate cancer compared to normal controls, benign prostatic hyperplasia, prostatitis and localised or recurrent disease. Here, IL6 is linked to medical procedure.